INDIA-DRUG Archives (by thread)

[india-drug] Banning of drugs in India (3), Dr Gurudas Khilnani

[india-drug] Clinical Research Training Courses (aarth-INDIA)(1), S.K.Tripathi

[india-drug] Query on Medicines, amit pachal

[india-drug] Low-Key Recall of AIDS Drug Hits World's Poor (2), Nusrat Shafiq

[india-drug] Novartis and Indian Patent Act (1), Dr Gopal Dabade

[india-drug] Mini Symposium at AIIMS, Dr. Madhur Gupta

[india-drug] Tirofiban, Liposomal Doxirubicin Or Vancomycin: A Query?, amit pachal

[india-drug] Introducing Essential Health Links at AED-SATELLIFE (1), Leela McCullough

[india-drug] P-drug or P-Medicine? (1), Dr Gurudas Khilnani

[india-drug] Tirofiban, Liposomal Doxorubicin Or Vancomycin: A Query? (2), Dr Gurudas Khilnani

[india-drug] Repository on Trade and Public Health, gopa kumar

[india-drug] Workshop on 'Fundamentals of GCP and Clinical Research' at Hyderabad (1), Bangera, Sudhakar

[india-drug] Price control for 'Branded Generic' medicines, anita kotwani
- RE: [india-drug] Price control for 'Branded Generic' medicines (2), anita kotwani
  - RE: [india-drug] Price control for 'Branded Generic' medicines (3), M.S.Ganachari

[india-drug] Novartis to move Indian R&D(1), Reji K Joseph

[india-drug] NPPA to look into the difference in bulk and retail prices (1), Reji K Joseph

RE: [india-drug] NPPA to look into the difference in bulk and retailprices (2), anita kotwani
- RE: [india-drug] NPPA to look into the difference in bulk and retailprices (3), tulsi chugh
- Re: [india-drug] NPPA to look into the difference in bulk andretailprices (4), BN Dhawan
- Re: [india-drug] NPPA to look into the difference in bulk and retail prices (5), ykykgupta@gmail.com
- RE: [india-drug] NPPA to look into the difference in bulk andretailprices (6), kamala krishnaswamy
  - RE: [india-drug] NPPA to look into the difference in bulkandretailprices (7), anita kotwani

[india-drug] "Novartis Boycott" campaign from Drug Action Forum (1), Dr Gopal Dabade

Mail converted by MHonArc 2.6.8